Host-microbiota interactions regulate gut serotonergic signaling: implications for hypertension
American Journal of Physiology-Cell Physiology · 01.12.2025 · 329 (6) · C1742-C1751
DOI: 10.1152/ajpcell.00608.2025 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Physiology-Cell Physiology, erschienen am 01.12.2025. Verfasst von Hemaa Sree Kumar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, United Sates. Hauptthemen laut MEDLINE: Serotonin, Gastrointestinal Microbiome, Hypertension, Gastrointestinal Tract. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 184 Literaturangaben. Gefördert von: HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI).
Abstract (Originalsprache)
Serotonin (5-hydroxytryptamine, 5-HT) is a highly conserved signaling molecule present across diverse taxa, including plants, invertebrates, and vertebrates. In mammals, the majority of peripheral serotonin is synthesized in the gastrointestinal tract by enteric neurons and enterochromaffin cells via tryptophan hydroxylases. Its biosynthesis and release are influenced by dietary components and microbial metabolites, particularly short-chain fatty acids produced by the gut microbiota. Once released into the periphery, serotonin exerts pleiotropic effects, regulating intestinal motility and secretion, modulating vascular tone, and influencing blood pressure through both direct actions and vagal sensory pathways engaging central and autonomic circuits. Dysregulation of colonic serotonin production or signaling has been implicated in metabolic, neuropsychiatric, and cardiovascular disorders, including postprandial blood pressure abnormalities and hypertension. Emerging evidence highlights a bidirectional relationship between gut microbes and host serotonergic pathways, suggesting that microbiota-targeted interventions may hold therapeutic potential for cardiometabolic regulation. Advancing our understanding of gut serotonergic signaling, particularly the interplay between host and microbial factors, could inform the development of innovative strategies to treat hypertension and related conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, United Sates.
- USF Center for Microbiome Research, Microbiomes Institute, University of South Florida Morsani College of Medicine, Tampa, Florida, United States.
- Department of Neurosurgery, Brain and Spine, University of South Florida Morsani College of Medicine, Tampa, Florida, United States.
ORCID-Profile: Hemaa Sree Kumar, Jasenka Zubcevic
Förderung
- HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
Zitieren
APA
Sree Kumar, H., & Zubcevic, J. (2025). Host-microbiota interactions regulate gut serotonergic signaling: implications for hypertension. American Journal of Physiology-Cell Physiology, 329(6), C1742-C1751. https://doi.org/10.1152/ajpcell.00608.2025
Vancouver
Sree Kumar H, Zubcevic J. Host-microbiota interactions regulate gut serotonergic signaling: implications for hypertension. American Journal of Physiology-Cell Physiology. 2025;329(6):C1742-C1751. doi:10.1152/ajpcell.00608.2025
BibTeX
@article{SreeKumar2025,
author = {Sree Kumar, Hemaa and Zubcevic, Jasenka},
title = {Host-microbiota interactions regulate gut serotonergic signaling: implications for hypertension},
journal = {American Journal of Physiology-Cell Physiology},
year = {2025},
volume = {329},
number = {6},
pages = {C1742--C1751},
doi = {10.1152/ajpcell.00608.2025}
}
EUVIMED